Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2021 October;112(5) > Minerva Medica 2021 October;112(5):661-3

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

LETTERS TO THE EDITOR   

Minerva Medica 2021 October;112(5):661-3

DOI: 10.23736/S0026-4806.20.06479-4

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

miR-26a inhibits the proliferation and migration of prostate cancer by targeting CDC6

Hui LI 1 , Weiran XU 2, Tian WANG 1, Chengfan YU 1, Xiaosong RAO 3, Xin HONG 1, Xiaofeng WANG 1

1 Department of Urologic Surgery, Peking University International Hospital, Beijing, China; 2 Department of Internal Medicine-Oncology, Peking University International Hospital, Beijing, China; 3 Department of Pathology, Peking University International Hospital, Beijing, China



inizio pagina